Back to AG ADAGE CAPITAL PARTNERS GP, L.L.C.

RPRXRPRX
25 quarters

Position history for AGADAGE CAPITAL PARTNERS GP, L.L.C.'s holdings in ROYALTY PHARMA PLC- CL A

ADAGE CAPITAL PARTNERS GP, L.L.C. holds 2.5M shares of RPRX (ROYALTY PHARMA PLC- CL A), worth $140.2M as of 2026-Q2. The position was decreased (-66.6% shares). RPRX represents 0.2% of ADAGE CAPITAL PARTNERS GP, L.L.C.'s portfolio.

Current Value

$140.2M

Current Shares

2.5M

Total Value Change

-$2.1B

Total Shares Change

-43.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.5M
-66.6%
$140.2M0.2%$55.85
0
2026-Q1
Decreased
7.5M
-36.3%
$358.8M0.6%$47.57
0
2025-Q4
Decreased
11.7M
-1.9%
$453.7M0.7%$38.12
0
2025-Q3
Increased
12M
+99.4%
$422.1M0.7%$34.61
71
2025-Q2
Decreased
6M
-4.0%
$216.2M0.4%$35.13
0
2025-Q1
Decreased
6.3M
-63.2%
$194.6M0.4%$30.15
0
2024-Q4
Increased
17M
+42.6%
$432.9M0.8%$24.55
59
2024-Q3
Increased
11.9M
+8.8%
$336.6M0.6%$27.00
48
2024-Q2
Increased
10.9M
+1.1%
$288.3M0.5%$24.97
44
2024-Q1
Decreased
10.8M
-0.7%
$328.5M0.6%$28.55
0
2023-Q4
Increased
10.9M
+10.7%
$306.1M0.6%$26.21
48
2023-Q3
Increased
9.8M
+13.8%
$267.1M0.6%$25.14
49
2023-Q2
Increased
8.7M
+19.4%
$265.9M0.6%$28.28
51
2023-Q1
Increased
7.2M
+3.5%
$261M0.6%$32.95
45
2022-Q4
Decreased
7M
-14.3%
$276.6M0.7%$35.95
0
2022-Q3
Decreased
8.2M
-51.1%
$328.1M0.8%$36.39
0
2022-Q2
Decreased
16.7M
-32.8%
$702.4M1.6%$37.91
0
2022-Q1
Unchanged
24.8M
0.0%
$967.9M1.8%$34.97
0
2021-Q4
Increased
24.8M
+0.6%
$990M1.8%$35.60
50
2021-Q3
Increased
24.7M
+8.7%
$892.6M1.8%$32.15
55
2021-Q2
Decreased
22.7M
-8.0%
$931.4M1.8%$36.31
0
2021-Q1
Decreased
24.7M
-36.2%
$1.1B2.2%$38.48
0
2020-Q4
Decreased
38.7M
-15.9%
$1.9B4.2%$44.00
0
2020-Q3
Unchanged
46M
0.0%
$1.9B4.8%$36.84
0
2020-Q2
New
46M
-
$2.2B5.7%$42.35
98

Other major holders of RPRX: MORGAN STANLEY, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used